Cell Nutrition That Delivers Young, Healthy T Cells For Your Process

The potential risks of contaminants and variability in cell therapy manufacturing can be reduced by using animal origin–free formulations like Gibco's CTS OpTmizer One Serum-Free Medium (SFM). Research indicates that CTS OpTmizer One SFM offers significant cell expansion with similar or improved cell viability compared to other media, for both diseased and healthy donor cells. The medium requires no mixing and is available in 1, 5, and 10 L bioprocess containers compatible with automated, closed cell therapy equipment. The future of cell therapy manufacturing will likely involve the use of such carefully designed media to minimize risks. The study also shows that acute myeloid leukemia (AML) donor cells achieved more consistent and robust expansion with the CTS OpTmizer One SFM compared to other suppliers' media. The product is intended for research use or manufacturing of cell, gene, or tissue-based products, not for direct administration into humans or animals.